Clinical Trial Update: Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating letrozole to improve outcomes and reduce costs in IVF-ET cycles for infertility was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Center for Human Reproduction | Conditions: Infertility | Phase 4 | Status: WITHDRAWN